| Description |
1 online resource (260 pages) |
| Series |
Fundamental and Clinical Cardiology |
|
Fundamental and clinical cardiology.
|
| Contents |
Front Cover; Introduction; Preface; Contents; Contributors; Chapter 1. Drug Discovery and Development; Chapter 2. Background Therapy in Congestive Heart Failure Studies; Chapter 3. Congestive Heart Failure Trial Design; Chapter 4. Angiotensin Converting Enzyme Inhibitors for Mortality Reduction in Congestive Heart Failure: Should Approval Be Granted for a Class Effect?; Chapter 5. Sudden Death in Congestive Heart Failure Trials; Chapter 6. Panel Discussion; Chapter 7. Antihypertensive Clinical Trials; Chapter 8. Calcium Channel Blockers: Safety Issues; Chapter 9. Panel Discussion |
|
Chapter 10. Antiarrhythmics: Indications, Claims, and Trial DesignChapter 11. Supraventricular Tachycardia Drugs and Trial Design Issues; Chapter 12. Antiarrhythmic Trials: Update; Chapter 13. Inter-Ethnic Differences in the Susceptibility to Drug-Induced QT Interval Prolongation and Torsade de Pointes; Chapter 14. Panel Discussion; Chapter 15. Antilipid Trial Endpoints; Chapter 16. Natural History Endpoints and Angina Trials; Chapter 17. Development of Antiplatelet Drugs; Chapter 18. Panel Discussion; Chapter 19. Future Directions of Cardiovascular Drug Development; Index; Back Cover |
| Summary |
These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process. Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs, and harmonizing international standards employed in the creation of vital new cardiovascular therapies! Cardiovascular Drug Developmentexplores the delicate balance of efficacy and safety that cardiovascular therapy must achieve to gain regulatory approval discusses the search for surrogates and the |
| Notes |
Print version record |
| Subject |
Cardiovascular agents -- Research -- Methodology -- Congresses
|
|
Cardiovascular agents.
|
|
Cardiovascular Agents
|
|
Cardiovascular agents.
|
| Genre/Form |
Conference papers and proceedings.
|
| Form |
Electronic book
|
| ISBN |
9781135550714 |
|
1135550719 |
|
